Apolipoprotein E recycling: implications for dyslipidemia and atherosclerosis.

After receptor-mediated endocytosis, the intracellular fate of triglyceride-rich lipoproteins (TRLs) is far more complex than the classical degradation pathway of low-density lipoproteins. Once internalized, TRLs disintegrate in peripheral endosomes, followed by a differential sorting of TRL components. Although core lipids and apolipoprotein B are targeted to lysosomes, the majority of TRL-derived apolipoprotein E (apoE) remains in peripheral recycling endosomes. This pool of TRL-derived apoE is then mobilized by high-density lipoproteins (HDLs) or HDL-derived apoA-I to be recycled back to the plasma membrane, followed by apoE resecretion and the subsequent formation of apoE-containing HDL. The HDL-induced recycling of apoE is accompanied by cholesterol efflux and involves the internalization and targeting of HDL-derived apoA-I to endosomes containing both apoE and cholesterol. These findings point to a yet unknown intracellular link between TRL-derived apoE, cellular cholesterol transport, and HDL metabolism. Recent studies provide first evidence that impaired recycling of TRL-derived apoE4, but not apoE3, is associated with intracellular cholesterol accumulation, which might explain some well-documented effects of apoE4 on HDL metabolism. This review summarizes the current understanding of apoE recycling and its potential role in the regulation of plasma apoE levels in the postprandial state.

[1]  Wenyan Lu,et al.  Sorting nexin 17 facilitates LRP recycling in the early endosome , 2005, The EMBO journal.

[2]  K. Weisgraber,et al.  The recycling of apolipoprotein E in macrophages: influence of HDL and apolipoprotein A-I. , 2005, Journal of lipid research.

[3]  M. Farlow,et al.  Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease Published, JLR Papers in Press, February 16, 2005. DOI 10.1194/jlr.M400486-JLR200 , 2005, Journal of Lipid Research.

[4]  Yonghe Li,et al.  Rapid Endocytosis of the Low Density Lipoprotein Receptor-related Protein Modulates Cell Surface Distribution and Processing of the β-Amyloid Precursor Protein* , 2005, Journal of Biological Chemistry.

[5]  Dipak P. Ramji,et al.  The key role of apolipoprotein E in atherosclerosis , 2005, Journal of Molecular Medicine.

[6]  K. Rye,et al.  Impaired Recycling of Apolipoprotein E4 Is Associated with Intracellular Cholesterol Accumulation* , 2004, Journal of Biological Chemistry.

[7]  I. Goldberg,et al.  Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk , 2004, Current atherosclerosis reports.

[8]  Jonathan C. Cohen,et al.  The Modular Adaptor Protein ARH Is Required for Low Density Lipoprotein (LDL) Binding and Internalization but Not for LDL Receptor Clustering in Coated Pits* , 2004, Journal of Biological Chemistry.

[9]  K. Weisgraber,et al.  The recycling of apolipoprotein E and its amino-terminal 22 kDa fragment: evidence for multiple redundant pathways. , 2004, Journal of lipid research.

[10]  B. Hyman,et al.  Serine and Threonine Phosphorylation of the Low Density Lipoprotein Receptor-related Protein by Protein Kinase Cα Regulates Endocytosis and Association with Adaptor Molecules* , 2004, Journal of Biological Chemistry.

[11]  R. Binder,et al.  Essential role of CD91 in re-presentation of gp96-chaperoned peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Brewer,et al.  The ABCA1 Transporter Modulates Late Endocytic Trafficking , 2004, Journal of Biological Chemistry.

[13]  R. Havel,et al.  Endocytosis of Hepatic Lipase and Lipoprotein Lipase into Rat Liver Hepatocytes in Vivo Is Mediated by the Low Density Lipoprotein Receptor-related Protein* , 2004, Journal of Biological Chemistry.

[14]  L. Lanningham-Foster,et al.  Harmful Effects of Increased LDLR Expression in Mice With Human APOE*4 But Not APOE*3 , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[15]  K. Weisgraber,et al.  Effects of Polymorphism on the Lipid Interaction of Human Apolipoprotein E* , 2003, Journal of Biological Chemistry.

[16]  J. Heeren,et al.  Recycling of Apoprotein E Is Associated with Cholesterol Efflux and High Density Lipoprotein Internalization* , 2003, The Journal of Biological Chemistry.

[17]  M. Linton,et al.  The Recycling of Apolipoprotein E in Primary Cultures of Mouse Hepatocytes , 2003, The Journal of Biological Chemistry.

[18]  C. Haass,et al.  Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts , 2003, The Journal of cell biology.

[19]  G. Kolovou,et al.  Apolipoprotein E Polymorphism and Atherosclerosis , 2003, Angiology.

[20]  B. Rupp,et al.  Apolipoprotein E4 Forms a Molten Globule , 2002, The Journal of Biological Chemistry.

[21]  R. Eckel,et al.  Lipoprotein lipase : genetics , lipid uptake , and regulation , 2002 .

[22]  Jonathan C. Cohen,et al.  ARH Is a Modular Adaptor Protein That Interacts with the LDL Receptor, Clathrin, and AP-2* , 2002, The Journal of Biological Chemistry.

[23]  M. Wolfe Therapeutic strategies for Alzheimer's disease , 2002, Nature Reviews Drug Discovery.

[24]  R. E. Pitas,et al.  Evidence for differential effects of apoE3 and apoE4 on HDL metabolism Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200172-JLR200 , 2002, Journal of Lipid Research.

[25]  Kai Simons,et al.  Cholesterol, lipid rafts, and disease. , 2002, The Journal of clinical investigation.

[26]  J. Heeren,et al.  Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo , 2002, Journal of Molecular Medicine.

[27]  A. Horwitz,et al.  Evaluation of the Role of Phosphatidylserine Translocase Activity in ABCA1-mediated Lipid Efflux* , 2002, The Journal of Biological Chemistry.

[28]  S. Younkin,et al.  Cholesterol-Dependent γ-Secretase Activity in Buoyant Cholesterol-Rich Membrane Microdomains , 2002, Neurobiology of Disease.

[29]  S. Younkin,et al.  Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains. , 2002, Neurobiology of disease.

[30]  J. Heeren,et al.  Recycling of Apolipoprotein E and Lipoprotein Lipase through Endosomal Compartments in Vivo * , 2001, The Journal of Biological Chemistry.

[31]  Robert V Farese,et al.  Introduction of human apolipoprotein E4 “domain interaction” into mouse apolipoprotein E , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  H. Brewer,et al.  Regulation and intracellular trafficking of the ABCA1 transporter. , 2001, Journal of lipid research.

[33]  M. Linton,et al.  A Recycling Pathway for Resecretion of Internalized Apolipoprotein E in Liver Cells* , 2001, The Journal of Biological Chemistry.

[34]  J. Heeren,et al.  Intracellular metabolism of triglyceride-rich lipoproteins , 2001, Current opinion in lipidology.

[35]  Jonathan C. Cohen,et al.  Autosomal Recessive Hypercholesterolemia Caused by Mutations in a Putative LDL Receptor Adaptor Protein , 2001, Science.

[36]  E. Kojro,et al.  Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  C. Bergmann,et al.  Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C. Schweiger [Statins and the risk of dementia]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[39]  M. Hennerici,et al.  Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  E. Kojro,et al.  Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. von Eckardstein,et al.  High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[42]  D. Small,et al.  Regulation of APP cleavage by α‐, β‐ and γ‐secretases , 2000 .

[43]  D. Riddell,et al.  Intramuscular injection of a plasmid vector expressing human apolipoprotein E limits progression of xanthoma and aortic atheroma in apoE-deficient mice. , 2000, Human molecular genetics.

[44]  P. Srivastava,et al.  CD91: a receptor for heat shock protein gp96 , 2000, Nature Immunology.

[45]  R. Walzem,et al.  Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[46]  L. Curtiss,et al.  Apolipoprotein E and atherosclerosis. , 2000, Current opinion in lipidology.

[47]  T. V. van Berkel,et al.  Apolipoprotein E Is Resistant to Intracellular Degradation in Vitro and in Vivo , 2000, The Journal of Biological Chemistry.

[48]  Q. Fan,et al.  Apolipoprotein E Exhibits Isoform‐Specific Promotion of Lipid Efflux from Astrocytes and Neurons in Culture , 2000, Journal of neurochemistry.

[49]  D. Small,et al.  Regulation of APP cleavage by alpha-, beta- and gamma-secretases. , 2000, FEBS letters.

[50]  R. Mahley,et al.  Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. , 1999, Journal of lipid research.

[51]  K. Cianflone,et al.  Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase. , 1999, Journal of lipid research.

[52]  D. Rader,et al.  Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[53]  Masahiko Watanabe,et al.  Apo E structure determines VLDL clearance and atherosclerosis risk in mice. , 1999, The Journal of clinical investigation.

[54]  M. Linton,et al.  Recycling of Apolipoprotein E in Mouse Liver* , 1999, The Journal of Biological Chemistry.

[55]  C. Mamotte,et al.  Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes. , 1999, The American journal of physiology.

[56]  J. Heeren,et al.  Intracellular processing of endocytosed triglyceride-rich lipoproteins comprises both recycling and degradation. , 1999, Journal of cell science.

[57]  R. Mahley,et al.  Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. , 1999, Journal of lipid research.

[58]  D. Dichek,et al.  Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice. , 1998, The Journal of clinical investigation.

[59]  B. Strooper,et al.  Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[60]  R. Hammer,et al.  Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. , 1998, The Journal of clinical investigation.

[61]  J. Heeren,et al.  Lipoprotein lipase (EC 3.1.1.34) targeting of lipoproteins to receptors , 1997, Proceedings of the Nutrition Society.

[62]  G. Siest,et al.  Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors. , 1996, Journal of lipid research.

[63]  A D Roses,et al.  Apolipoprotein E alleles as risk factors in Alzheimer's disease. , 1996, Annual review of medicine.

[64]  R. Havel,et al.  Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele. , 1996, The Journal of clinical investigation.

[65]  A. von Eckardstein,et al.  Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma. , 1995, The Journal of clinical investigation.

[66]  H. Brewer,et al.  Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors. , 1995, The Journal of clinical investigation.

[67]  A. Mcclelland,et al.  Phenotypic correction of hypercholesterolemia in apoE-deficient mice by adenovirus-mediated in vivo gene transfer. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[68]  D. Agard,et al.  Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. , 1994 .

[69]  N. Maeda,et al.  The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Stephen W. Scheff,et al.  Induction of Alzheimer-like β-Amyloid Immunoreactivity in the Brains of Rabbits with Dietary Cholesterol , 1994, Experimental Neurology.

[71]  R. Frants,et al.  Inefficient degradation of triglyceride-rich lipoprotein by HepG2 cells is due to a retarded transport to the lysosomal compartment. , 1993, The Journal of biological chemistry.

[72]  F. Maxfield,et al.  Beta-very low density lipoprotein is sequestered in surface-connected tubules in mouse peritoneal macrophages , 1993, The Journal of cell biology.

[73]  V. Ord,et al.  Abundant expression of apoprotein E by macrophages in human and rabbit atherosclerotic lesions. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[74]  J. Dallongeville,et al.  Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. , 1992, Journal of lipid research.

[75]  F. Maxfield,et al.  The influence of particle size and multiple apoprotein E-receptor interactions on the endocytic targeting of beta-VLDL in mouse peritoneal macrophages , 1991, The Journal of cell biology.

[76]  G. Bengtsson-Olivecrona,et al.  Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[77]  F. Maxfield,et al.  Endocytosed beta-VLDL and LDL are delivered to different intracellular vesicles in mouse peritoneal macrophages , 1990, The Journal of cell biology.

[78]  K. Weisgraber Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. , 1990, Journal of lipid research.

[79]  U. Beisiegel,et al.  The LDL–receptor–related protein, LRP, is an apolipoprotein E-binding protein , 1989, Nature.

[80]  R. Gregg,et al.  Abnormal in vivo metabolism of apolipoprotein E4 in humans. , 1986, The Journal of clinical investigation.

[81]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[82]  R. Mahley,et al.  Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. , 1981, The Journal of clinical investigation.

[83]  E. Quinet,et al.  Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. , 1980, The Journal of clinical investigation.

[84]  J. Little,et al.  Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. , 1978, The New England journal of medicine.